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Abstract 
A unique example of Pd-catalyzed decarboxylative dehydrogenation of fully substituted N-acyl allyl enol carbonates is enabled by a new 
electron deficient phosphinooxazoline (PHOX) ligand. The reaction proceeds from the Z-enol carbonate to provide dehydrogenation 
products  exclusively in high E/Z selectivity, while the E-enol carbonate provides the α-allylation product with only minor 
dehydrogenation. The reaction proceeds with a broad scope of (Z)-enol carbonates derived from N-acyl indoles to furnish acyclic formal 
α,β-unsaturated  ester  equivalents. 
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Introduction 
Our lab has recently become interested in developing 
palladium-catalyzed asymmetric allylic alkylation 
reactions of acyclic stereodefined fully substituted enol 
carbonates to generate acyclic quaternary stereogenic 
centers.  In our initial efforts, we reported the application 
of a highly E-selective enolization1 of acylic α-aryl 
ketones to generate stereodefined fully substituted acyclic 
ketone enol carbonates which we employed in a highly 
enantioselective Pd-catalyzed allylic alkylation to generate 
all carbon quaternary centers.2  More recently, we became 
intrigued by the possibility of extending this reactivity 
toward acyclic ester enolate equivalents to generate α-
quaternary carboxylic acid derivatives.  In our initial 
optimization of this transformation, we investigated new 
electron deficient phosphinooxazoline (PHOX) ligands 
with N-acyl hetereocycle derived enol carbonates as ester 
enolate equivalents. To our delight, we found that the 
combination of N-acyl indole derived enol carbonate 1 and 
fluorinated ligand (S)-F13-t-BuPHOX afforded allylation 
product 2 in an excellent 94% ee and promising 80% yield 
(Scheme 1).  Further investigation of this reaction revealed 
that despite excellent conversion of 1, allylation product 2 
was isolated in only 80% yield with a 15% yield of α,β-
unsaturation product 3a.  Surprisingly, when a 79:21 Z/E 
mixture of enol carbonate 1 was utilized, α,β-unsaturation 
product 3a predominated, suggesting a preference for the 
Z-enol carbonate to undergo α,β-dehydrogenation rather 
than a standard α-alkylation.  Control experiments 
revealed that the reaction does not proceed in the absence 
of (S)-F13-t-BuPHOX ligand with either enol carbonate 
mixture, instead providing >95% recovery of the starting 
material with unaffected E/Z enol carbonate ratios.  The 
high synthetic value of α,β-unsaturated carboxylic acids 
and their derivatives coupled with the limited synthetic 
methods which enable access to this motif prompted 
further investigation of this unusual reactivity with our 
newly synthesized fluorinated PHOX ligand.  
Numerous distinct strategies have been developed to 
access α,β-unsaturated moieties from carbonyl and 
carboxylic acid motifs including selenium,3 sulfur,4 
hypervalent iodine,5 and quinone6 based transformations, 
as well as palladium catalyzed dehydrogenations.7 One-
step allyl-palladium catalyzed dehydrogenations have 
recently been developed by Newhouse, with pioneering 
studies from Tsuji,8 as an effective method to generate 
 α,β-unsaturated carbonyls,9 carboxylic acids,10 and 
carboxylic acid derivatives,11 however, there are limited 
examples regarding acyclic systems bearing α-
substitution, especially in high E/Z selectivity.  Moreover, 
to the best of our knowledge, this is the first example of an 
electron deficient PHOX ligand promoting 
dehydrogenation reactivity with an allyl-palladium 
species.  This new reactivity complements the available 
methodology for the generation of α,β-unsaturated 
compounds and could serve as a new avenue for 
methodology development in the α,β-unsaturation of 
carbonyl compounds. 
 
2. Results and discussion 
We began our investigation with an examination of the 
ligand system (Table 1).  To our surprise, when analogous 
achiral F13-glyPHOX ligand was employed, no reaction 
occurred even with elevated reaction temperatures of up to 
60 ºC (Table 1, entry 1).  Though the t-Bu group was 
required on the ligand scaffold, both enantiomeric series of 
the F13-t-BuPHOX provided α,β-dehydrogenation product 
3a in essentially identical yield and E/Z selectivity (entries 
2 and 3).  These results demonstrate that this unique 
resolution of the enol carbonate geometries is likely the 
result of the electron withdrawing nature of the F13-t-
BuPHOX ligand in combination with the preference for 
dehydrogenation of the Z-enol carbonate.  While the E-
enol carbonate can be obtained with excellent selectivity 
(generally >98:2) utilizing previously reported selective 
enolization conditions1a, selective formation of the Z-enol 
carbonate is more challenging with modest selectivity of 
79:21 Z/E obtained in THF with KHMDS as the base 
(Scheme 2).   
Table 1. Investigation of the ligand.a 
Conditions: a 0.2 mmol substrate, 0.5 mol % Pd2(dba)3, 1.2 mol % ligand, 2.0 
mL solvent, 25 °C.  b Yields of isolated products.  E/Z ratios measured by 1H 
NMR integration.  Scheme 1. Initial reaction discovery. 
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n of the reaction aimed to identify conditions which 
favored dehydrogenation for both enol carbonate 
geometries.  Other solvents common for dehydrogenation 
reactions were examined, but provided no improvement 
over the 3:1 hexanes/toluene solvent system (Table 2, 
entries 1–6).  With either toluene or MTBE as a solvent 
full conversion of 1 is observed, albeit with lower 
selectivity for dehydrogenation product 3a over alkylation 
product 2 compared with 3:1 hexanes/toluene (entries 2 
and 3).  In THF, the reaction becomes sluggish and 65% of 
the enol carbonate mixture is recovered after 24 h with no 
change in the ratio of enol carbonates (entry 4).  Polar, 
aprotic solvents such as DMF and MeCN utilized in allyl-
palladium catalyzed dehydrogenation by Tsuji8 provide no 
reaction (entries 5 and 6).  Newhouse and co-workers have 
previously demonstrated the application of zinc salts to 
disfavor allylation via a postulated transmetalation to 
afford a less nucleophilic zinc enolate in allyl-palladium 
catalyzed dehydrogenations.9–11  To our disappointment, 
the incorporation of ZnCl2 in our reaction conditions as a 
stoichiometric additive stymies both allylation and 
dehydrogenation pathways (entry 7). Heating the reaction 
with a 75:25 Z/E mixture of 1 to 60 ºC also fails to 
promote any measurable level of conversion.  Notably, 
when ZnCl2 is used with a >98:2 E/Z mixture of enol 
carbonates, trace conversion to the allylation product is 
observed after prolonged heating (>24 h) at 60 ºC, further 
exemplifying the importance of enolate geometry in this 
transformation.  In addition, we found N-acyl indole 
derived enol carbonate 1 was incompatible with Tsuji’s 
classic decarboxylative dehydrogenation conditions,8a 
instead providing complex mixtures of decarboxylative 
allylation and protonation with recovered enol carbonate 
(Scheme 3).  
 
 
Bereft of reaction conditions favoring dehydogenation 
for both enolate geometries, we examined the reaction 
scope with pure Z-enol carbonates to simplify reaction 
analysis and product purification.  A variety of N-acyl 
indoles were enolized using Z-selective conditions (vide 
supra) and trapped as the corresponding allyl enol 
carbonates.  The geometrically pure Z-enol carbonates 
were then isolated by preparative chromatography and 
subjected to our standard reaction conditions (Table 3).  
Pleasingly, a broad range of alkyl and aryl group 
substitutions were well tolerated under the reaction 
conditions and  α,β-unsaturated products were obtained in 
high yield and excellent E-selectivity.  With pure Z-enol 
carbonate 1, product 3a was obtained in >99% yield and in 
10:1 E/Z selectivity.  Unsubstituted compound 3b was 
obtained in 84% yield despite elevated potential to 
undergo intermolecular conjugate addition during the 
course of the reaction.  Longer alkyl chains were well 
tolerated with n-butyl product 3c isolated in 97% yield and 
15:1 E/Z selectivity.  Sterically encumbered i-propyl 
product 3d was also well tolerated with >98:2 E 
selectivity, albeit in a diminished 77% yield.  Product 3e 
bearing 1,2- diphenyl substitution could be obtained in 
75% yield and 6:1 E/Z selectivity.  A variety of aryl 
groups were also compatible with the dehydrogenation 
reaction. Notably, ortho-substituted product 3f was 
obtained in an excellent 91% yield and 10:1 E/Z 
selectivity.  Electron rich p-OMe-C6H4 aryl compound 3g 
was isolated in an excellent 94% yield and 18:1 E/Z 
selectivity.  Finally, products with electron poor aryl 
groups p-F-C6H4 (3h) and p-Cl-C6H4 (3i) were also 
obtained in high yields (89% and 79% yield, respectively) 
and excellent E-selectivity (12:1 and 8:1 E/Z, 
respectively).  
While we were pleased with the scope of α,β-
unsaturated N-acyl indoles afforded by the Pd-catalyzed 
decarboxylative dehydrogenation, we ultimately desired to 
extend this methodology toward a general manifold of 
carbonyl compounds. In these initial efforts, we 
deternubed this reaction was unsuccessful with other 
substrates commonly utilized in Pd-catalyzed asymmetric 
decarboxylative allylic alkylation in our laboratory (Figure 
1). Cyclic allyl enol carbonate 4 and β-ketoesters 5–7 
failed to convert to either allylation or dehydrogenation 
products with these reaction conditions.  Even with the 
Scheme 2. E- and Z-selective enol carbonate formation. 
Table 2. Optimization of the Pd-catalyzed dehydrogenation. 
Conditions: a 0.2 mmol substrate, 0.5 mol % Pd2(dba)3, 1.2 mol % ligand, 2.0 
mL solvent, 25 °C, 24 h reaction time.  b Yields of isolated products.  E/Z ratios 
measured by 1H NMR integration.  c Incomplete conversion.  d Reaction 
performed at 40 ºC.  e Reaction performed at 60 ºC. 
Scheme 3. Investigation of Tsuji’s classic dehydrogenation. 
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analogous acyclic phenyl ketone derived allyl enol 
carbonate 8 (75:25 Z/E) no conversion was observed.  
Future efforts will be directed toward  investigation of the 
dehydrogenation reaction with substrate classes 
unsuccessful in this unique system toward a more general 
transformation and understanding the nature of the ligand 
promoted dehydrogenation. 
We posit a plausible catalytic cycle for this 
transformation can proceed as shown in Figure 2 where 
the allyl group of the enol carbonate ultimately serves as a 
hydride acceptor.  A ligated Pd0 species can undergo 
oxidative addition to allyl enol carbonate 1, generating 
palladium carboxylate 9.  Subsequent decarboxylation 
produces allyl palladium complex 10 and enolate 11 which 
can form carbon-bound palladium enolate 12.  At this 
stage, β-hydride elimination can occur to furnish product 
3a and palladium hydride 13.  Finally, reductive 
elimination of 13 regenerates the Pd0 species and generates 
propene as a by-product.  
 
 
 
 
 
3. Conclusion and outlook 
In summary, we have developed the first 
example of an allyl-palladium catalyzed decarboxylative 
dehydrogenation reaction of fully substituted N-acyl indole 
derived allyl enol carbonates promoted by a newly 
developed electron deficient PHOX ligand.  The reaction 
was quite general with respect to N-acyl indole derived 
allyl enol carbonates and occurs only with F13-t-BuPHOX 
ligand. Other substrate classes typically utilized in 
decarboxylative allylic alkylation in our laboratory proved 
unreactive.  Future efforts will aim to probe the nature of 
this unusual resolution of enolate geometries and expand 
this methodology into a more general transformation for 
α,β-dehydrogenation. Ultimately, this methodology 
provides new precedent for ligand controlled selectivity of 
dehydrogenation over allylic alkylation with allyl-
palladium catalysis. 
4. Selected experimentals 
4.1 General 
Unless otherwise stated, reactions were performed in 
flame-dried glassware under an argon or nitrogen 
atmosphere using dry, deoxygenated solvents.  Solvents 
were dried by passage through an activated alumina 
column under argon. Reaction progress was monitored by 
thin-layer chromatography (TLC) or Agilent 1290 UHPLC-
MS.  TLC was performed using E. Merck silica gel 60 F254 
precoated glass plates (0.25 mm) and visualized by UV 
fluorescence quenching, p-anisaldehyde, or KMnO4 
staining.  Silicycle SiliaFlash® P60 Academic Silica gel 
(particle size 40–63 nm) was used for flash 
chromatography. The Z-enol carbonates were purified by 
Table 3. Substrate scope of the Pd-catalyzed decarboxylative 
dehydrogenation.a 
a
 Conditions: 0.2 mmol substrate, 0.5 mol % Pd2(dba)3, 1.2 mol % ligand, 
2.0 mL solvent, 25 °C, 16 h reaction time. Yields of isolated product. 
Product E/Z ratios were measured by 1H NMR integration. 
 
Figure 1. Unsuccessful substrates for the Pd-catalyzed 
decarboxylative dehydrogenation. 
Figure 2. Plausible catalytic cycle. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 
5
preparative LC on a Teledyne Isco ACCQPrep HP125; 
column: C–18, 100 Å, 5 µm, ID 20 mm. 1H NMR spectra 
were recorded on Varian Inova 500 MHz and Bruker 400 
MHz spectrometers and are reported relative to residual 
CHCl3 (δ 7.26 ppm).  
13C NMR spectra were recorded on a 
Varian Inova 500 MHz spectrometer (125 MHz) and 
Bruker 400 MHz spectrometers (100 MHz) and are 
reported relative to CHCl3 (δ 77.16 ppm). Data for 
1H NMR 
are reported as follows: chemical shift (δappm) 
(multiplicity, coupling constant (Hz), integration).  
Multiplicities are reported as follows: s = singlet, d = 
doublet, t = triplet, q = quartet, p = pentet, sept = 
septuplet, m = multiplet, br s = broad singlet, br d = broad 
doublet.  Data for 13C NMR are reported in terms of 
chemical shifts (δappm).  IR spectra were obtained by use 
of a Perkin Elmer Spectrum BXII spectrometer or Nicolet 
6700 FTIR spectrometer using thin films deposited on 
NaCl plates and reported in frequency of absorption (cm–
1).  Optical rotations were measured with a Jasco P-2000 
polarimeter operating on the sodium D-line (589 nm), 
using a 100 mm path-length cell. High resolution mass 
spectra (HRMS) were obtained from Agilent 6200 Series 
TOF with an Agilent G1978A Multimode source in 
electrospray ionization (ESI+), atmospheric pressure 
chemical ionization (APCI+), or mixed ionization mode 
(MM: ESI-APCI+). Reagents were purchased from 
commercial sources and used as received unless 
otherwise stated.  
 
4.2 General procedure for dehydrogenation 
A representative procedure for the decarboxylative 
dehydrogenation of N-acyl indole derived enol carbonates: 
In a nitrogen-filled glovebox, a solution of Pd2(dba)3 
(1.8 mg/mL) and (S)-F13-t-BuPHOX (2.8 mg/mL) in toluene 
was stirred for 30 min at 25 °C, then 0.5 mL of the 
resulting catalyst solution was added to a one dram vial 
containing the allyl enol carbonate substrate (0.2 mmol) 
dissolved in hexanes (1.5 mL).  The vial was sealed with a 
Teflon-lined cap, removed from the glovebox, and stirred 
at 25 °C for 16 h unless noted otherwise.  The crude 
reaction mixture was concentrated then purified by silica 
gel flash chromatography to provide the desired 
dehydrogenation product. 
 
4.2.1 (E)-1-(1H-indol-1-yl)-2-phenylbut-2-en-1-one (3a) 
Purified by column chromatography (5% Et2O in hexanes) 
to provide a colorless oil (52.1 mg, 0.199 mmol, >99% 
yield, 10:1 E/Z); 1H NMR (400 MHz, CDCl3) δ 8.47 (dq, J = 
8.3, 0.9 Hz, 1H), 7.54 (dq, J = 7.6, 0.8 Hz, 1H), 7.43–7.27 
(m, 8H), 6.50 (dd, J = 3.8, 0.7 Hz, 1H), 6.46 (q, J = 7.2 Hz, 
1H), 1.99 (d, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 
169.2, 138.0, 136.0, 134.9, 134.6, 130.8, 129.1, 128.8, 
128.2, 127.2, 125.6, 125.0, 123.9, 120.9, 116.7, 108.5, 
15.3; IR (Neat Film, NaCl) 3054, 2918, 2854, 1682, 1585, 
1535, 1495, 1472, 1451, 1385, 1359, 1331, 1240, 1204, 
1158, 1144, 1079, 1016, 946, 881, 815, 752, 703 cm–1; 
HRMS (MM:ESI-APCI+) m/z calc’d for C18H16NO [M+H]
+: 
262.1226, found 262.1222. 
 
4.2.2 1-(1H-indol-1-yl)-2-phenylprop-2-en-1-one (3b) 
Purified by column chromatography (5% Et2O in hexanes) 
to provide a colorless oil (41.4 mg, 0.167 mmol, 84% 
yield);1H NMR (400 MHz, CDCl3) δ 8.57–8.54 (m, 1H), 7.57 
(dt, J = 7.7, 1.0 Hz, 1H), 7.51–7.45 (m, 2H), 7.43–7.28 (m, 
6H), 6.54 (d, J = 3.7 Hz, 1H), 6.08 (s, 1H), 5.70 (s, 1H); 13C 
NMR (100 MHz, CDCl3) δ 168.7, 144.5, 135.7, 135.4, 
131.0, 129.2, 129.2, 127.1, 126.2, 125.3, 124.3, 121.0, 
118.6, 116.8, 109.3; IR (Neat Film, NaCl) 3055, 2926, 1692, 
1535, 1496, 1471, 1450, 1378, 1348, 1293, 1205, 1156, 
1072, 1016, 931, 880, 752, 696 cm–1; HRMS (MM:ESI-
APCI+) m/z calc’d for C17H14NO [M+H]
+: 248.1070, found 
248.1063. 
 
4.2.3 (E)-1-(1H-indol-1-yl)-2-phenylhept-2-en-1-one (3c) 
Purified by column chromatography (3% Et2O in hexanes) 
to provide a colorless oil (58.9 mg, 0.194 mmol, 97% yield, 
14:1 E/Z); 1H NMR (400 MHz, CDCl3) δ 8.47 (d, J = 8.3 Hz, 
1H), 7.54 (dd, J = 7.5, 0.9 Hz, 1H), 7.42 – 7.26 (m, 7H), 
6.57–6.48 (m, 2H), 6.33 (t, J = 7.5 Hz, 1H), 2.36 (q, J = 7.5 
Hz, 2H), 1.50 (tt, J = 8.2, 6.9 Hz, 2H), 1.37 (dq, J = 14.4, 7.2 
Hz, 2H), 0.89 (t, J = 7.3 Hz, 3H); 13C NMR (100 MHz, CDCl3) 
δ 169.2, 140.2, 136.8, 136.0, 135.2, 130.8, 129.0, 128.8, 
128.2, 127.2, 125.0, 123.9, 120.9, 116.7, 108.5, 31.5, 28.9, 
22.6, 14.0; IR (Neat Film, NaCl) 3053, 2957, 2928, 2858, 
1688, 1636, 1600, 1585, 1534, 1494, 1472, 1450, 1379, 
1333, 1205, 1157, 1143, 1113, 1078, 1016, 938, 882, 816, 
769, 752, 702 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for 
C21H22NO [M+H]
+: 304.1696, found 304.1688. 
4.2.4 (E)-1-(1H-indol-1-yl)-4-methyl-2-phenylpent-2-en-
1-one (3d) 
Purified by column chromatography (3% Et2O in hexanes) 
to provide a colorless oil (44.3 mg, 0.153 mmol, 77% yield, 
>20:1 E/Z); 1H NMR (400 MHz, CDCl3) δ 8.46 (dd, J = 8.3, 
1.0 Hz, 1H), 7.55 (ddd, J = 7.7, 1.3, 0.7 Hz, 1H), 7.42–7.27 
(m, 8H), 6.54 (d, J = 3.8 Hz, 1H), 6.10 (d, J = 10.5 Hz, 1H), 
2.80 (dhept, J = 10.5, 6.6 Hz, 1H), 1.11 (d, J = 6.6 Hz, 6H); 
13C NMR (100 MHz, CDCl3) δ 169.2, 146.6, 136.0, 135.3, 
134.5, 130.9, 128.9, 128.8, 128.8, 127.2, 125.0, 123.9, 
120.9, 116.7, 108.5, 28.3, 22.7; IR (Neat Film, NaCl) 3054, 
2962, 2868, 1687, 1534, 1494, 1450, 1377, 1334, 1238, 
1201, 1112, 1078, 1017, 882, 795, 769, 752, 698 cm–1; 
HRMS (MM:ESI-APCI+) m/z calc’d for C20H20NO [M+H]
+: 
290.1539, found 290.1528. 
 
4.2.5 (E)-1-(1H-indol-1-yl)-2,3-diphenylprop-2-en-1-one 
(3e) 
Purified by column chromatography (5% Et2O in hexanes) 
to provide a colorless oil (48.3 mg, 0.149 mmol, 75% yield, 
6:1 E/Z); 1H NMR (400 MHz, CDCl3) δ 8.67 (d, J = 8.2 Hz, 
1H), 7.70 (dd, J = 11.3, 7.5 Hz, 2H), 7.65 (d, J = 3.8 Hz, 1H), 
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7.59–7.44 (m, 7H), 7.44–7.30 (m, 5H), 6.71 (d, J = 3.8 Hz, 
1H); 13C NMR (100 MHz, CDCl3) δ 169.2, 136.4, 136.1, 
135.3, 134.6, 130.9, 130.0, 129.3, 129.2, 128.9, 128.7, 
128.5, 127.1, 126.0, 125.1, 124.1, 121.0, 116.8, 108.9.; IR 
(Neat Film, NaCl) 3053, 3026, 2923, 1684, 1535, 1492, 
1472, 1450, 1381, 1333, 1235, 1206, 1155, 1141, 1112, 
1077, 1016, 908, 882, 862, 753, 721, 694 cm–1; HRMS 
(MM:ESI-APCI+) m/z calc’d for C23H18NO [M+H]
+: 
324.1383, found 324.1380. 
 
4.2.6 (E)-1-(1H-indol-1-yl)-2-(o-tolyl)but-2-en-1-one (3f) 
Purified by column chromatography (3% Et2O in hexanes) 
to provide a colorless oil (50.1 mg, 0.182 mmol, 91% yield, 
12:1 E/Z); 1H NMR (400 MHz, CDCl3) δ 8.40 (d, J = 8.2 Hz, 
1H), 7.46 (dd, J = 7.7, 1.1 Hz, 1H), 7.31–7.26 (m, 1H), 7.25 
(d, J = 3.8 Hz, 1H), 7.22–7.16 (m, 3H), 7.12 (d, J = 7.9 Hz, 
2H), 6.42 (d, J = 3.8 Hz, 1H), 6.35 (q, J = 7.2 Hz, 1H), 2.28 
(s, 3H), 1.91 (d, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) 
δ 169.4, 138.0, 137.9, 135.9, 134.0, 131.9, 130.8, 129.7, 
129.5, 128.9, 127.2, 125.5, 124.9, 123.9, 120.8, 116.7, 
108.4, 21.4, 15.3; IR (Neat Film, NaCl) 3027, 2919, 2856, 
1688, 1533, 1513, 1472, 1450, 1384, 1329, 1239, 1206, 
1157, 1143, 1113, 1080, 1017, 946, 882, 828, 770, 753, 
723 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for C19H18NO 
[M+H]+: 276.1383, found 276.1375. 
 
4.2.7 (E)-1-(1H-indol-1-yl)-2-(4-methoxyphenyl)but-2-en-
1-one (3g) 
Purified by column chromatography (8% Et2O in hexanes) 
to provide a colorless oil (55.0 mg, 0.189 mmol, 94% yield, 
19:1 E/Z); 1H NMR (400 MHz, CDCl3) δ 8.48 (d, J = 8.3 Hz, 
1H), 7.54 (d, J = 7.7 Hz, 1H), 7.41–7.24 (m, 5H), 6.96–6.87 
(m, 2H), 6.50 (d, J = 3.8 Hz, 1H), 6.40 (q, J = 7.1 Hz, 1H), 
3.81 (s, 3H), 1.99 (d, J = 7.1 Hz, 3H).;13C NMR (100 MHz, 
CDCl3) δ 169.6, 159.4, 137.6, 135.9, 133.6, 130.8, 130.3, 
127.3, 127.2, 124.9, 123.9, 120.8, 116.7, 114.2, 108.4, 
55.4, 15.3; IR (Neat Film, NaCl) 2934, 2361, 1684, 1607, 
1511, 1450, 1328, 1292, 1250, 1202, 1178, 1110, 1079, 
1032, 948, 881, 838, 815, 770, 753 cm–1; HRMS (MM:ESI-
APCI+) m/z calc’d for C19H18NO2 [M+H]
+: 292.1332, found 
292.1340. 
 
4.2.8 (E)-2-(4-fluorophenyl)-1-(1H-indol-1-yl)but-2-en-1-
one (3h) 
Purified by column chromatography (5% Et2O in hexanes) 
to provide a colorless oil (49.8 mg, 0.178 mmol, 89% yield, 
13:1 E/Z); 1H NMR (400 MHz, CDCl3) δ 8.45 (d, J = 8.2 Hz, 
1H), 7.55 (dt, J = 7.7, 0.9 Hz, 1H), 7.40–7.32 (m, 4H), 7.32–
7.26 (m, 1H), 7.13–7.06 (m, 2H), 6.53 (d, J = 3.8 Hz, 1H), 
6.45 (q, J = 7.1 Hz, 1H), 1.96 (d, J = 7.1 Hz, 3H); 13C NMR 
(100 MHz, CDCl3) δ 169.0, 162.45 (d, JC–F = 248.2 Hz), 
136.9, 135.9, 134.9, 130.9, 130.8, 127.0, 125.1, 124.0, 
120.9, 116.6, 116.0, 115.7, 108.7, 15.2; 19F NMR (282 
MHz, CDCl3) δ –113.18 (dtq, J = 10.8, 5.3, 2.3 Hz).IR (Neat 
Film, NaCl) 3051, 2917, 1685, 1602, 1534, 1509, 1472, 
1450, 1385, 1331, 1224, 1202, 1160, 1101, 1080, 1016, 
948, 881, 842, 786, 770, 754 cm–1; HRMS (MM:ESI-APCI+) 
m/z calc’d for C18H15FNO [M+H]
+: 280.1132, found 
280.1137.  
4.2.9 (E)-2-(4-chlorophenyl)-1-(1H-indol-1-yl)but-2-en-1-
one (3i) 
Purified by column chromatography (5% Et2O in hexanes) 
to provide a colorless oil (46.7 mg, 0.158 mmol, 79% yield, 
8:1 E/Z); 1H NMR (400 MHz, CDCl3) δ 8.45 (d, J = 8.1 Hz, 
1H), 7.59–7.51 (m, 1H), 7.40–7.26 (m, 7H), 6.53 (d, J = 3.7 
Hz, 1H), 6.46 (q, J = 7.2 Hz, 1H), 1.97 (d, J = 7.1 Hz, 3H); 13C 
NMR (100 MHz, CDCl3) δ 168.7, 136.9, 135.9, 135.3, 
134.2, 133.2, 130.4, 129.2, 129.0, 127.0, 125.1, 124.1, 
120.9, 116.6, 108.8, 15.3; IR (Neat Film, NaCl) 3051, 2916, 
1688, 1534, 1491, 1472, 1451, 1384, 1330,  1204, 1143, 
1089, 1016, 947, 881, 838, 802, 770, 754 cm–1; HRMS 
(MM:ESI-APCI+) m/z calc’d for C18H15ClNO [M+H]
+: 
296.0837, found 296.0835. 
 
Supplementary data 
     NMR spectra for compounds 3a–3i, as well as 
experimental and characterization data for substrate and 
ligand synthesis. 
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